ProPhase Labs, Inc. (PRPH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

USANA Health Sciences, Inc.

Nature's Sunshine Products, Inc.

Chromadex Corp.

ProPhase Labs, Inc.

LifeVantage Corp.

Natural Alternatives International, Inc.

Upexi, Inc.

Revolution Medicines, Inc.

Cidara Therapeutics, Inc.

MIRA Pharmaceuticals, Inc.

Bright Green Corp.

Why is ProPhase Labs, Inc. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

The company has been able to generate a Return on Equity (avg) of 9.38% signifying low profitability per unit of shareholders funds

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -97.16%, its profits have risen by 19.3%

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -4.2% over the previous quarter and collectively hold 7.28% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -97.16% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is ProPhase Labs, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

ProPhase Labs, Inc.

-97.16%

-0.08

1252.21%

S&P 500

20.6%

1.55

13.08%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-15.29%

EBIT Growth (5y)

-252.99%

EBIT to Interest (avg)

0.30

Debt to EBITDA (avg)

Net Debt to Equity (avg)

0.48

Sales to Capital Employed (avg)

0.59

Tax Ratio

23.71%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

11.48%

ROCE (avg)

13.43%

ROE (avg)

9.38%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.20

EV to EBIT

-0.44

EV to EBITDA

-0.58

EV to Capital Employed

0.58

EV to Sales

1.54

PEG Ratio

Dividend Yield

ROCE (Latest)

-132.40%

ROE (Latest)

-292.87%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -16.49% (YoY

OPERATING PROFIT(Q)

Highest at USD -1.46 MM

PRE-TAX PROFIT(Q)

Highest at USD -3.43 MM

EPS(Q)

Highest at USD -0.42

-1What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 726.27% (YoY

Here's what is working for ProPhase Labs, Inc.

Operating Profit

Highest at USD -1.46 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -3.43 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -3.43 MM has Grown at 45.02%

over average net sales of the previous four periods of USD -6.23 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

EPS

Highest at USD -0.42

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -16.49% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for ProPhase Labs, Inc.

Raw Material Cost

Grown by 726.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales